Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-08-14

FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE from Rising Pharma Holdings, Inc., to support its ongoing use as a combination the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL AND HYDROCHLOROTHIAZIDE (captopril and hydrochlorothiazide)

Snippet

SUPPL AP for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (CAPTOPRIL AND HYDROCHLOROTHIAZIDE)